FI963831A7 - Farmaseuttinen yhdistelmävalmiste hormonaalista ehkäisyä varten - Google Patents

Farmaseuttinen yhdistelmävalmiste hormonaalista ehkäisyä varten Download PDF

Info

Publication number
FI963831A7
FI963831A7 FI963831A FI963831A FI963831A7 FI 963831 A7 FI963831 A7 FI 963831A7 FI 963831 A FI963831 A FI 963831A FI 963831 A FI963831 A FI 963831A FI 963831 A7 FI963831 A7 FI 963831A7
Authority
FI
Finland
Prior art keywords
pharmaceutical preparation
combined pharmaceutical
hormonal contraception
contraception
hormonal
Prior art date
Application number
FI963831A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963831A0 (fi
Inventor
Ursula Lachnit
Bernd Duesterberg
Juergen Spona
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6514578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI963831(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI963831A0 publication Critical patent/FI963831A0/fi
Publication of FI963831A7 publication Critical patent/FI963831A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
FI963831A 1994-03-30 1996-09-25 Farmaseuttinen yhdistelmävalmiste hormonaalista ehkäisyä varten FI963831A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4411585A DE4411585A1 (de) 1994-03-30 1994-03-30 Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
PCT/EP1995/001190 WO1995026730A1 (fr) 1994-03-30 1995-03-30 Preparation pharmaceutique combinee de contraception hormonale

Publications (2)

Publication Number Publication Date
FI963831A0 FI963831A0 (fi) 1996-09-25
FI963831A7 true FI963831A7 (fi) 1996-11-29

Family

ID=6514578

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963831A FI963831A7 (fi) 1994-03-30 1996-09-25 Farmaseuttinen yhdistelmävalmiste hormonaalista ehkäisyä varten

Country Status (25)

Country Link
US (1) US5756490A (fr)
EP (1) EP0750501B1 (fr)
JP (1) JPH09511243A (fr)
KR (1) KR100352571B1 (fr)
CN (1) CN1108800C (fr)
AT (1) ATE222494T1 (fr)
AU (1) AU2073595A (fr)
BG (1) BG63192B1 (fr)
BR (1) BR9507251A (fr)
CA (1) CA2186739A1 (fr)
CZ (1) CZ291698B6 (fr)
DE (2) DE4411585A1 (fr)
DK (1) DK0750501T3 (fr)
ES (1) ES2181770T3 (fr)
FI (1) FI963831A7 (fr)
HU (1) HUT75521A (fr)
NO (1) NO964089L (fr)
NZ (1) NZ282824A (fr)
PL (1) PL316569A1 (fr)
PT (1) PT750501E (fr)
RO (1) RO118375B1 (fr)
RU (1) RU2165258C2 (fr)
SK (1) SK124396A3 (fr)
UA (1) UA41401C2 (fr)
WO (1) WO1995026730A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
ES2218556T3 (es) * 1994-11-22 2004-11-16 Balance Pharmaceuticals, Inc. Metodos de contracepcion.
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
AU726283B2 (en) * 1995-06-28 2000-11-02 Schering Aktiengesellschaft Pharmaceutical combined preparations, kit and method for hormonal contraception
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
AU2815897A (en) * 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
CN1119999C (zh) * 1996-07-26 2003-09-03 惠氏公司 口服避孕药
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
WO1998004267A1 (fr) * 1996-07-26 1998-02-05 American Home Products Corporation Contraceptif oral a base de progestine et d'oestrogene
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
DE69729956T2 (de) * 1996-07-26 2004-12-16 Wyeth Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
CN1223350C (zh) * 1999-08-31 2005-10-19 先灵公司 用作避孕剂的炔雌醇和屈螺酮的药物联合形式
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP2305267A3 (fr) 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Combinaison pharmaceutique de l'éthinylestradiol et de la drospirénone pour utilisation comme contraceptif
JP4354667B2 (ja) * 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
CN100581550C (zh) * 2001-12-05 2010-01-20 杜拉美德药物有限公司 预防怀孕和减少经期前症状的口服避孕药
CN101001631B (zh) * 2003-07-16 2014-08-06 特卫华妇女健康有限公司 利用连续给予雌激素的避孕方案的激素治疗方法
WO2005032558A1 (fr) * 2003-10-01 2005-04-14 Janssen Pharmaceutica N.V. Regimes contraceptifs triphasiques etendus
EP1535618A1 (fr) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Préparation pharmaceutique pour le traitement hormonal continuel sur plus de 21-28 jours comprenant deux compositions d'estrogène et/ou de progestine
US20050113350A1 (en) * 2003-11-26 2005-05-26 Bernd Duesterberg Extended use combination comprising estrogens and progestins
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
EP1993531B1 (fr) * 2006-03-02 2015-10-14 Warner Chilcott Company, LLC Procédé de contraception orale multiphase à cycles prolongés
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (fr) * 1966-11-02 1968-05-03
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
RU2043105C1 (ru) * 1987-11-04 1995-09-10 Центр по химии лекарственных средств Контрацептивное средство
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
DE4104385C1 (fr) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
PT750501E (pt) 2003-01-31
PL316569A1 (en) 1997-01-20
BG63192B1 (bg) 2001-06-29
CN1108800C (zh) 2003-05-21
BG100940A (en) 1998-03-31
DE59510333D1 (de) 2002-09-26
CZ291698B6 (cs) 2003-05-14
CZ287996A3 (en) 1997-02-12
HUT75521A (en) 1997-05-28
FI963831A0 (fi) 1996-09-25
NO964089L (no) 1996-11-07
NZ282824A (en) 1998-07-28
SK124396A3 (en) 1997-05-07
DK0750501T3 (da) 2002-12-23
ES2181770T3 (es) 2003-03-01
EP0750501B1 (fr) 2002-08-21
EP0750501A1 (fr) 1997-01-02
BR9507251A (pt) 1997-09-02
DE4411585A1 (de) 1995-10-05
UA41401C2 (uk) 2001-09-17
JPH09511243A (ja) 1997-11-11
RO118375B1 (ro) 2003-05-30
MX9604440A (es) 1997-07-31
US5756490A (en) 1998-05-26
RU2165258C2 (ru) 2001-04-20
KR100352571B1 (ko) 2003-01-06
WO1995026730A1 (fr) 1995-10-12
CN1159161A (zh) 1997-09-10
NO964089D0 (no) 1996-09-27
HU9602657D0 (en) 1996-11-28
AU2073595A (en) 1995-10-23
ATE222494T1 (de) 2002-09-15
CA2186739A1 (fr) 1995-10-12

Similar Documents

Publication Publication Date Title
FI963831A7 (fi) Farmaseuttinen yhdistelmävalmiste hormonaalista ehkäisyä varten
HUP9900252A2 (hu) Hormonális fogamzásgátló, kombinációs kit készítmény
FI20071025L (fi) Farmaseuttisia koostumuksia
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
DK0936913T4 (da) Oralt farmaceutisk præparat indeholdende ibandronat
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
DK0998272T3 (da) Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
FI950947L (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
DK1466615T3 (da) Farmaceutisk præparat
PT868911E (pt) Formulacoes de rapamicina para administracao oral
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
EP0907644A4 (fr) Preparation pharmaceutique
GB9408053D0 (en) Pharmaceutical preparation
BR9507768A (pt) Composição farmacêutica
ID16781A (id) Formulasi-formulasi farmasi
ITMI941169A0 (it) Formulazioni farmaceutiche
PT939083E (pt) Complexos de ferro-succinilcaseina procedimento para sua preparacao e suas composicoes farmaceuticas
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI951155L (fi) Farmaseuttinen valmiste
FI962738A0 (fi) Farmaseuttiset koostumukset
FI954050A7 (fi) Lääkekoostumuksia
BR9603673A (pt) Preparado de combinação farmacêutica compreendendo cetoprofeno
EP0998934A4 (fr) Remedes contre les maladies intramedullaires
SK1380U (sk) Farmaceutický preparát

Legal Events

Date Code Title Description
FD Application lapsed